We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.51B Turnover 51.11%
1-Year Est. Return 5.32%
This Fund
S&P 500
This Quarter Est. Return
+2.72%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.44B
AUM Growth
-$2.12B
Cap. Flow
-$1.01B
Cap. Flow %
-70.43%
Top 10 Hldgs %
44.76%
Holding
213
New
76
Increased
14
Reduced
26
Closed
68
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.1 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.1 years
Top 20 Avg Time Held Equity only
0.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 77.44%
2 Healthcare 4.92%
3 Technology 4.77%
4 Consumer Discretionary 3.39%
5 Financials 3.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TSPQ.U
101
DELISTED
TCW Special Purpose Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third of one redeemable warrant
TSPQ.U
$538K 0.04%
54,000
-196,000
-78% -$1.96M
2021 Q1
1 quarter
TBCP
102
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
$524K 0.04%
+54,000
New +$529K
2021 Q2
0 quarters
LGAC
103
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$489K 0.03%
+50,000
New +$491K
2021 Q2
0 quarters
ACTDU
104
DELISTED
ArcLight Clean Transition Corp. II Unit
ACTDU
$489K 0.03%
+48,000
New +$486K
2021 Q2
0 quarters
HLAH
105
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Class A Common Stock
HLAH
$488K 0.03%
50,000
-250,000
-83% -$2.44M
2021 Q1
1 quarter
HTPA
106
DELISTED
Highland Transcend Partners I Corp.
HTPA
$486K 0.03%
+50,000
New +$491K
2021 Q2
0 quarters
GTPB
107
DELISTED
Gores Technology Partners II, Inc. Class A Common
GTPB
$478K 0.03%
+48,000
New +$476K
2021 Q2
0 quarters
GSQD
108
DELISTED
G Squared Ascend I Inc.
GSQD
$474K 0.03%
+48,000
New +$472K
2021 Q2
0 quarters
FRXB
109
DELISTED
Forest Road Acquisition Corp. II
FRXB
$470K 0.03%
+48,000
New +$470K
2021 Q2
0 quarters
FATH icon
110
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$467K 0.03%
+2,400
New +$471K
2021 Q2
0 quarters
LBTYA icon
111
Liberty Global Class A
LBTYA
$2.66B
$466K 0.03%
17,151
-169,260
-91% -$4.57M
2020 Q1
5 quarters
CORZ icon
112
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$433K 0.03%
+44,000
New +$434K
2021 Q2
0 quarters
MBAC.WS
113
CALL
DELISTED
M3-Brigade Acquisition II Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
MBAC.WS
$385K 0.03%
+333,333
New +$279K
2021 Q2
0 quarters
COCHW icon
114
CALL
Envoy Medical Warrant
COCHW
$376K 0.03%
+391,665
New +$279K
2021 Q2
0 quarters
REVHU
115
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Units
REVHU
$362K 0.03%
36,000
-64,000
-64% -$648K
2021 Q1
1 quarter
FACA.WS
116
CALL
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$300K 0.02%
+217,375
New +$284K
2021 Q2
0 quarters
VTIQ
117
DELISTED
VectoIQ Acquisition Corp. II Class A Common Stock
VTIQ
$220K 0.02%
22,000
-78,000
-78% -$772K
2021 Q1
1 quarter
MMAC
118
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$204K 0.01%
+7,500
New +$162K
2021 Q2
0 quarters
ISEE
119
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$189K 0.01%
+30,000
New +$194K
2021 Q2
0 quarters
GNW icon
120
Genworth Financial
GNW
$3.43B
$39K ﹤0.01%
10,000
– –
2020 Q4
2 quarters
DMYQ.WS
121
CALL
DELISTED
dMY Technology Group, Inc. IV Redeemable warrants, each whole warrant exercisable for one share of C
DMYQ.WS
$27K ﹤0.01%
+19,200
New +$25.3K
2021 Q2
0 quarters
AUS.WS
122
CALL
DELISTED
Austerlitz Acquisition Corporation I Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
AUS.WS
$23K ﹤0.01%
+18,749
New +$27.2K
2021 Q2
0 quarters
AAL icon
123
PUT
American Airlines Group
AAL
$7.86B
– –
-310,000
Closed -$7.41M –
ATEX icon
124
CALL
Anterix
ATEX
$1.58B
– –
-100,800
Closed -$4.75M –
BMRN icon
125
CALL
BioMarin Pharmaceuticals
BMRN
$10.6B
– –
-25,000
Closed -$1.89M –

Similar funds

DLD Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, DLD Asset Management held 213 positions worth $1.44B, down 60% from $3.56B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

DLD Asset Management withdrew a net $1.01B in Q2 2021, closing 68 positions and reducing 26 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $101M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 79% a quarter earlier, followed by Healthcare and Technology.

Against the trend, DLD Asset Management opened a new position in Envoy Medical worth $11.4M.

  • DLD Asset Management's largest Q2 2021 buy was Envoy Medical: 1,175,000 shares worth $11.4M.
  • DLD Asset Management added most to Kansas City Southern in Q2 2021, an estimated $15.9M increase.
  • DLD Asset Management's biggest Q2 2021 reduction was Willis Towers Watson, cutting an estimated $54.4M.
  • DLD Asset Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $101M.
  • DLD Asset Management's ten largest holdings make up 45% of its $1.44B portfolio in Q2 2021.
  • DLD Asset Management opened 76 new positions and closed 68 in Q2 2021.
  • DLD Asset Management's portfolio value fell 60% quarter-over-quarter to $1.44B.

Based on DLD Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.